Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety, Tolerability, Pharmacokinetics and Pharmacodynamics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Early research (Phase 1)Study completedNCT06649630
What this trial is testing

A Study Looking at How Different Doses of Study Medicine (Inno8) Works in the Body of Healthy Men

Who this might be right for
Haemophilia A
Novo Nordisk A/S 95
Early research (Phase 1)Study completedNCT01336244
What this trial is testing

GLPG0778: Multiple Ascending Oral Doses, Pharmacokinetic, Safety, and Pharmacodynamic Study

Who this might be right for
Healthy
Lakefront Biotherapeutics NV 45
Early research (Phase 1)Study completedNCT01898364
What this trial is testing

Safety and Efficacy Evaluation of Repeat neoGAA Dosing in Late Onset Pompe Disease Patients.

Who this might be right for
Pompe DiseaseGlycogen Storage Disease Type II (GSD II)Acid Maltase Deficiency
Genzyme, a Sanofi Company 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05120830
What this trial is testing

NTLA-2002 in Adults With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
Intellia Therapeutics 37
Early research (Phase 1)Active Not RecruitingNCT06637371
What this trial is testing

A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma

Who this might be right for
Asthma
Amgen 21
Testing effectiveness (Phase 2)Study completedNCT01225211
What this trial is testing

Study of VX-809 Alone and in Combination With VX-770 in Cystic Fibrosis (CF) Patients Homozygous or Heterozygous for the F508del-CFTR Mutation

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 312
Early research (Phase 1)Looking for participantsNCT05318534
What this trial is testing

Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Male and Female Subjects and Safety, Tolerability, Pharmacokinetics, and Pilot Efficacy Biomarkers in Subjects With Cold Agglutinin Disease

Who this might be right for
First in Man Study to Evaluate Initial Safety
Gliknik Inc. 70
Early research (Phase 1)UnknownNCT02836834
What this trial is testing

Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of an Anti-PD-1 mAb for Patients With Advanced Solid Tumors

Who this might be right for
LymphomaLung Cancer
Shanghai Junshi Bioscience Co., Ltd. 33
Early research (Phase 1)Active Not RecruitingNCT06205628
What this trial is testing

Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension

Who this might be right for
HypertensionHypertension,Essential
ADARx Pharmaceuticals, Inc. 28
Early research (Phase 1)Looking for participantsNCT07376707
What this trial is testing

TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors

Who this might be right for
CRC (Colorectal Cancer)Melanoma (Skin Cancer)HCC - Hepatocellular Carcinoma+1 more
Hefei TG ImmunoPharma Co., Ltd. 194
Early research (Phase 1)Study completedNCT00820092
What this trial is testing

Xerecept Intravenous Dose Escalation in Japanese and Caucasian Volunteers

Who this might be right for
Edema
Celtic Pharma Development Services 38
Early research (Phase 1)UnknownNCT03242512
What this trial is testing

Assessment of Anti-RANKL Antibody in Post-menopausal Women

Who this might be right for
Osteoporosis
Jiangsu T-Mab Biopharma Co.,Ltd 24
Early research (Phase 1)Study completedNCT04008992
What this trial is testing

An Ascending Dose Study of BMS-986259 to Study Safety in Healthy Participants

Who this might be right for
Healthy Participants
Bristol-Myers Squibb 132
Early research (Phase 1)Ended earlyNCT04752371
What this trial is testing

Evaluate Camoteskimab in Participants With Still's Disease

Who this might be right for
Adult Onset Still's Disease
Apollo Therapeutics Ltd 5
Early research (Phase 1)Ended earlyNCT02254161
What this trial is testing

Multiple Rising Dose of BI 1181181 Given Orally in Young Healthy Male and Elderly Healthy Male/Female Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 36
Early research (Phase 1)Study completedNCT00354042
What this trial is testing

Effects Of Repeat Inhaled Doses Of GW597901X On Patient Safety And Lung Function In Asthmatic Subjects

Who this might be right for
Asthma
GlaxoSmithKline 24
Testing effectiveness (Phase 2)Study completedNCT01054729
What this trial is testing

Dose-Ranging Study of Sofosbuvir in Combination With Pegylated Interferon and Ribavirin in Treatment Naïve GT 1 HCV Patients

Who this might be right for
Hepatitis C
Gilead Sciences 64
Early research (Phase 1)Study completedNCT01620931
What this trial is testing

A Single-Ascending-Dose Study of RO5469754 in Healthy Volunteers

Who this might be right for
Healthy Volunteer
Hoffmann-La Roche 36
Early research (Phase 1)Study completedNCT03478319
What this trial is testing

ACE-2494 in Healthy Subjects

Who this might be right for
Healthy Volunteers
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 48
Next Page